Unveiled: Terumo’s NaviCross Support Catheters for PAD

Unveiled: Terumo’s NaviCross Support Catheters for PAD

Terumo Medical has launched its NaviCross Support Catheter line for snaking through vasculature Terumo NaviCross Unveiled: Terumos NaviCross Support Catheters for PADwhen intervening during treatment of peripheral artery disease (PAD) and Critical Limb Ischemia (CLI).

Featuring Terumo Glide Technology™ hydrophilic coating and a seamless guidewire-to-catheter transition, the NaviCross has been designed for accessing and tracking through even the most complex lesions. The shaft incorporates a stainless steel double-braided layer, combined with a 12mm tapered tip, giving it best-in-class pushability*. The catheter is compatible with .035” wire platforms and 4Fr sheaths and is available with a straight or 30 degree angled tip allowing access to vascular branches including below the knee (BTK) collaterals. It features 3 radiopaque marker bands to facilitate accurate assessment of position, while their unique spacing provides easy measurement of common balloon and stent sizes.

“The design of the NaviCross allows for true 1:1 torque with complete force transmission from my hand to the tip of the catheter without lag time or delay,” said Dr. Jihad Mustapha, Director of Endovascular Interventions and Director of Cardiovascular Research at Metro Heart & Vascular, Metro Health Hospital, Wyoming, MI. “It excels in long length lesions and is ideal for any chronic or highgrade stenoses that are located in or at an angulated vessel segment. One of the most superior support catheters for pushability, crossability, trackabilty, torquability, and (tip) visualization, there is also no buckling, which (may) lower the risk of dissection and perforations.”

SOMERSET, NJ (March 23, 2012) — Terumo Interventional Systems, a strategic business unit

of Terumo Medical Corporation, today announced the expansion of its peripheral catheter portfolio with

the nationwide availability of its new line of NaviCross™ Support Catheters, designed to provide

interventionalists with significantly greater wire support for the access and treatment of peripheral artery

disease (PAD) and Critical Limb Ischemia (CLI).

Featuring Terumo Glide Technology™ hydrophilic coating and a seamless guidewire-to-catheter

transition, the NaviCross has been designed for accessing and tracking through even the most complex

lesions. The shaft incorporates a stainless steel double-braided layer, combined with a 12mm tapered tip,

giving it best-in-class pushability*. The catheter is compatible with .035” wire platforms and 4Fr sheaths

and is available with a straight or 30 degree angled tip allowing access to vascular branches including

below the knee (BTK) collaterals. It features 3 radiopaque marker bands to facilitate accurate

assessment of position, while their unique spacing provides easy measurement of common balloon and

stent sizes.

“The design of the NaviCross allows for true 1:1 torque with complete force transmission from

my hand to the tip of the catheter without lag time or delay,” said Dr. Jihad Mustapha, Director of

Endovascular Interventions and Director of Cardiovascular Research at Metro Heart & Vascular, Metro

Health Hospital, Wyoming, MI. “It excels in long length lesions and is ideal for any chronic or highgrade

stenoses that are located in or at an angulated vessel segment. One of the most superior support

catheters for pushability, crossability, trackabilty, torquability, and (tip) visualization, there is also no

buckling, which (may) lower the risk of dissection and perforations.”

- more -

(Terumo Launches NaviCross Support Catheters …page 2)

“The NaviCross Support Catheter is Terumo Interventional Systems’ first entry into the support

catheter category,” said said Chris Pearson, Vice President, Marketing, Terumo Interventional Systems.

“As the leaders in entry site management and lesion access, we feel this catheter is the perfect

complement to our comprehensive peripheral portfolio of wires, catheters, and sheaths. NaviCross was

specifically engineered for simplicity with best-in-class safety and performance in mind and is designed

to excel when used with Terumo’s market leading Glidewire®. It allows our customers to confidently

treat most peripheral lesions, without the need for more expensive crossing devices or therapies.”

For more information about the NaviCross Support Catheters, customers can contact Terumo

Interventional Systems by calling its Inside Sales Specialist Team at 800-862-4143 or by visiting

www.terumois.com.

*Data on file

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly

markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization

products for use in a multitude of different interventional procedures. Interventional Radiologists,

Interventional Neuroradiologists, Interventional Cardiologists, and Vascular Surgeons are among the

medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions,

thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation

Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops,

manufactures, and markets high-quality medical devices used in a broad range of applications in

numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site

management products, and a line of sterile connection devices used in hospitals and blood banks

worldwide.

Terumo Corporation

Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $4.0

billion in sales and operations in more than 160 nations. Founded in 1921, the company develops,

manufactures, and distributes world-class medical devices including products for use in cardiothoracic

surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad

array of syringe and hypodermic needle products for hospital and physician office use. Terumo

contributes to society by providing valued products and services to the healthcare market and by

responding to the needs of healthcare providers and the people they serve.

- more -

(Terumo Launches NaviCross Support Catheters …page 3)

Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543,

Reuters symbol, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s

leading stock index.

Source : www.FINAL-NaviCross-Press-Release-3-22-12.pdf

Related Posts Plugin for WordPress, Blogger...
Be Sociable, Share!

About the Author

has written 1822 posts on this blog.

Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes